Archive for 2017

Be Like Ben – and Make This Move by Dec. 18

0 | By Michael A. Robinson

A friend of mine, Ben, did what many of us dream about a few years back.

He was in middle management, deeply ensconced in a big accounting firm in downtown San Francisco. It paid great, but Ben hated the job: long hours, a ridiculous commute, tons of boring meetings, eating lunch at the desk every day. You know the routine.

But unlike so many of us, Ben took action. He regained his freedom.

He quit his job, cashed out some of his investments, moved to the country, and became an independent trucker.

He loves it. He loves chatting with other truckers, eating at greasy spoons, listening to talk radio all day, being his own boss… pretty much.

But he also hates it, sometimes. That’s because Ben’s “boss,” such as it is, is a computer that tells him where to go, when to get there, when to pull over to fill up or for maintenance, even when to go to bed.

Yup, like I tell you so often, every business is a tech business – even trucking.

A few years back, I showed you folks one way to cash in on tech’s takeover of trucking by recommending FleetCor Technologies Inc. (NYSE: FLT), a commercial fleet-focused electronic payments company. And if you made that move, you’re sitting on some pretty big gains – 135.8%.

FleetCor still has plenty of room to run – up to 20% in just the next 12 months.

But there’s another trucking technology investment out there that I want to tell you about. And I need to tell you about it now – today.

That’s because midnight, Dec. 18, a little-known federal mandate will go into effect across the United States.

It requires the immediate deployment of a cutting-edge technology for the trucking industry. It’s “Ben’s boss.”

I call it an Augmented Digital Copilot – or ADC for short. (I can’t tell you what Ben calls it.)

And just one tiny company has meticulously developed the technology to dominate this market. Only it can fulfill the immense and imminent demand for these devices.

This small, under-the-radar firm is on the verge of earning a big chunk of the $2 billion windfall that this federal mandate is creating.

That will send its stock soaring and make its investors a fortune.

Now here’s how you can “be like Ben” – and regain your own freedom

Instead of Lamenting Cyber Monday’s “Retail Apocalypse,” Make This Move

0 | By Michael A. Robinson

Black Friday/Cyber Monday hit about two weeks ago – and all I’ve heard since is doom and gloom.

The “retail apocalypse” is here, and every “expert” out there is telling investors to “Short” brick-and-mortar retailers… wait, no, they should “Buy” retailers on the dip.

Then there are those who try to explain that this isn’t really an apocalypse, and that this specific retailer is going to survive (but this one or this one isn’t).

Over at Jim Cramer’s TheStreet, I saw one writer recommend an ETF – EMTY, as in “empty” stores – whose share price rises whenever a bricks-and-mortar retail stock index falls.

All this is ridiculous – and way more complicated than necessary.

Yes, Macy’s Inc. (NYSE: M), Sears Holdings Corp. (Nasdaq: SHLD), and Office Depot Inc. (ODP) are plummeting. And, indeed, J. Crew Group Inc. and Toys “R” Us Inc. are heading toward insolvency.

But check out these numbers…    

Adobe Analytics tracked $5.03 billion in online sales on Black Friday – and an even more robust $6.59 billion on Cyber Monday. And the analysts there think the stage is now set for e-commerce sales to surpass $100 billion this holiday season, a new record.

In other words, technology is behind all the “apocalypse.” So instead of picking among retailers to “Buy” and/or “Short,” we should be investing in the technology that’s causing the “apocalypse.”

And though it’s a good start, we can do way more than “Buy” Amazon.com Inc. (Nasdaq: AMZN).

In fact, we can get into an e-commerce-focused investment that’s been doubling the overall market’s return all year long.

And that shows no sign of slowing down…

These Four Stocks Are the Most Dangerous Dogs on Wall Street

0 | By Michael A. Robinson

Call it the “Millennial Market.”

No, I’m not talking about how twenty- and thirtysomethings are affecting the market.

Instead, I’m talking about how we now measure the advance of the bellwether Dow Jones Industrial Average not by hundreds, but by thousands.

The Doe has advanced by 1,000 points by five times this year… so far.

In fact, it took just 30 days for it to reach 24,000 on Nov. 30.

That’s great news for just about every investor.

But the news is even better for investors like you.

For technology investors, the Nasdaq Composite set 69 new highs so far this year. It has gained 23.3%, which is 49.5% better than the S&P 500 and 15.7% better than the Dow.

Meanwhile, Bitcoin is up 1,075% in 2017 – and Ethereum has soared an amazing 5,371.4%.

And in legal marijuana, my premium Nova-X Report members have made triple-digit gains on several of the penny pot stocks in their model portfolio. To find out how to join them, just click here.

In other words, ground-floor trends like technology, cryptocurrencies, and legal marijuana are the driving forces behind the market’s historic gains.

But that doesn’t mean you can just blindly buy any tech stock out there and expect to make money.

While I know you don’t believe that’s true, some of you might buy into Wall Street’s hype machine – and believe you can make a fortune on some of the troubled tech leaders they’re touting as “turnaround” investments in 2018.

Don’t believe that hype.

Especially don’t believe any hype you might hear about these 2018 Tech Dogs.

These are the four stocks you want to stay as far away as possible from next year. They’re dangerous – all four of them.

Take a look – and then keep away… far away…

While Wall Street Keeps “Watching” This Sector, You Can Make a Killing

1 | By Michael A. Robinson

If you follow the chip sector, you might be confused.

Check out what’s happened in just the past month…

On Nov. 3 we learned that Marvell Technology Group Ltd. (Nasdaq: MRVL) is in talks to buy Cavium Inc. (Nasdaq: CAVM). The pact would create a chip firm worth some $14 billion but the deal is yet to be consummated. 

But that was small potatoes compared to what came next.

On Nov. 13, Qualcomm Inc. (Nasdaq: QCOM) rejected a $105 billion buyout offer from Broadcom Ltd. (Nasdaq: AVGO) – what would have been the biggest tech buyout in history. As a leading supplier of mobile-chip technology, Qualcomm says it’s better off operating on its own rather than merge with.

And all that comes after Qualcomm offered $39 billion to buy NXP Semiconductors NV (Nasdaq: NXPI). At the time, that was the record amount for a chip sector takeover.

Moreover, Wall Street analysts seem to be constantly putting the semiconductor sector on “watch” – saying the current chip surge is about to run out… today… tomorrow… next week.

But they’re always wrong.

If you’re not sure where you should be putting your money after mixed messages like that, I understand. Like I said, it gets confusing.

However, you do want some money in semiconductors.

See, the chip industry is consolidating not out of weakness, but strength.

A recent report by industry trade group SEMI forecasts that silicon shipments will hit 11.49 billion square inches this year, 11.8 billion next year, and 12.24 billion in 2019. Total shipments of “wafers” – the format silicon is produced in – for this year will break the record set back in 2016. And shipments will continue at record levels for each of the next two years.

And that’s just one robust forecast – I’ll show you a couple more below.

Still, if you’re not up for picking and choosing among the acquirers and acquireds, there is a way to make money off the on again/off again Qualcomm-Broadcom merger, the Marvell-Cavium lockup, and just about any other chip-sector M&A that comes along.

It’s a wallet-expanding way to profit from the chip sector’s ascendance and merger mania in a way that is crushing the market by nearly threefold

These Federal Regulators Are Dead Wrong on Marijuana – Again

0 | By Michael A. Robinson

Not long ago, the U.S. Department of Justice indicated that it would keep on giving leeway to states that have legalized cannabis, even though marijuana remains illegal at the federal level.

Then yesterday, the DOJ hinted that it would begin cracking down on recreational marijuana – and soon.

“In fact, we’re looking at that very hard right now, we had a meeting yesterday and talked about it at some length,” U.S. Attorney General Jeff Sessions said at a press conference yesterday. “It’s my view that the use of marijuana is detrimental, and we should not give encouragement in any way to it, and it represents a federal violation, which is in the law and is subject to being enforced… We are working our way through to a rational policy, but I don’t want to suggest in any way that this department believes that marijuana is harmless and people should not avoid it.”

Bless his heart.

Now I admire Sessions a lot. I’m with him on big priorities like fighting crime… stopping illegal immigration… and supporting local police departments.

But he has been and continues to be dead wrong on legal recreational marijuana.

The genie is out of the bottle.

Legal Marijuana ETF Is Up 36% in First 8 Months – but You Can Do a Lot Better Than That

1 | By Michael A. Robinson

In 2013, the market for medically “sanctioned’ marijuana was worth about $1.5 billion.

It’s expected to reach $6.7 billion this year – and $35 billion by 2020. And by 2029: The market is projected to reach $100 billion.

Those are hefty numbers.

So no wonder we got so excited when legal marijuana joined the ETF game about eight months back.

click here.

Coming Jan. 1: Legal Marijuana’s Biggest Trigger Yet

2 | By Michael A. Robinson

Even after stacking up a bunch of double-, triple- and even quadruple-digit gains over the last year and a quarter, many of my Roadmap to Marijuana Millions pot stocks still have plenty of gas left.

In fact, a few of my Canadian legal marijuana plays in particular been on fire for months now – and especially since Nov. 10.

That’s the day Canada’s Department of Finance presented its cannabis tax plan on. The Canadian government plans to add a $1-per-gram excise tax on cannabis products, or 10% of the sale price, whichever is higher. Plus, the tax plan reiterated Canada’s commitment to legalize marijuana by July 2018.

No wonder my readers’ “Fast Fortune” Canadian pot stocks jumped higher.

One of those stocks rose 15% the day that news broke… another soared 10% that day… another jumped 6.8%… and another picked up13%.

But today we’re talking about the one that gained 15% on Nov. 10. We’re focusing on that one because it’s gone on to soar 76% since then thanks to another catalyst entirely. And it’s gained an amazing 766% since I first alerted my readers to it back in September 2016.

Today, I’ll tell you about that stock – and the “second” catalyst that boosted its gains.

Plus, I’ve identified another “trigger” that’s going to boost pot stocks on Jan. 1.

I want you to get in on these stocks before that catalyst hits.

And before mainstream investors catch on…

Legal Marijuana’s Western Frontier Is Primed for Business

0 | By Michael A. Robinson

The hottest sector in the stock market is about to undergo an incredibly unique “trigger.”

As you know, legal marijuana is already booming in the 29 U.S. states where recreational and/or medical cannabis is legal.

Now comes the full legalization of weed in the nation’s most populous state.

Click here.

These Three Stocks Are Where Marijuana and Dividends Intersect

3 | By Michael A. Robinson

I love when you folks send me questions.

I love it even more when your questions lead me to an investing idea I can then share with you.

A lot of you ask me about tech dividend stocks. You’re looking for the growth of tech stocks – along with the income dividend payers provide.

That makes a lot of sense to me.

Even more of you ask me about pot stocks – and how to invest in them.

And just recently one of you asked me about dividend-paying legal cannabis stocks – about whether they even exist.

Well, they do.

After all, every Venn diagram has its union.

Of course, most cannabis growers and dispensaries haven’t been established long enough to make a profit, let alone pay a portion of their profits to shareholders in the form of dividends.

However, there are marijuana “pick-and-shovel” plays that offer hefty dividends.

Here are three of my favorite marijuana dividend stock plays now, plus one that is set to soar in the coming weeks…

This Pick Is Just What the Software Engineer Ordered

1 | By Michael A. Robinson

I’m not average.

For one, I’m a bit taller than the average guy. My hair went silver earlier than I expected. And I’m fortunate that it’s easier for me to keep trim than a lot of people I know.

On the downside, I’ve got various allergies and genetic maladies that most folks don’t.

My environment isn’t average either. Here in Silicon Valley and the San Francisco Bay Area, I spend my days in some of the most polluted cities in the United States. Of course, in other ways, this region rates much higher than most of America.

Then there are my habits. For example, I eat well, but don’t get to the gym enough.

I bet you’re the same way – but different.

No one is average.

And that’s why it often seems like maintaining a healthy diet, getting plenty of exercise, and regular checkups just aren’t enough to keep us healthy. If it were, no one would gain too much weight, go bald at 30, or get cancer.

By our very nature, each of us is so unique that this one-size-fits-all approach just isn’t enough.

That’s what opened the door for an emerging field known as precision medicine. The idea here is to set up disease prevention and treatment measures for each and every individual, accounting for your genes, environment, and lifestyle… for my genes, environment, and lifestyle.

Think of it as a partnership – a “convergence” – among traditional medicine, molecular biology, data analysis, and cloud computing.

Doctors and other medical diagnosticians collect our info, and then feed it to the cloud. There software and data scientists can crunch through all that data – and then use what they turn up to prescribe precise disease treatments and preventative measures for each individual.

Mordor Intelligence has run the numbers – and says precision medicine will be worth $59.2 billion by 2021

And I’ve spotted a hidden way to play this hot new field with a stock with which you’ll soon be quadrupling the market’s return